A lthough our medical school has been created more than a century ago, clinical oncology, as an organized and comprehensive discipline, has a relatively recent history. For a long time, education in clinical oncology was spread through various clinical and surgical disciplines in the undergraduate curriculum from
Although a remarkable progress has been achieved, cancer is still an important cause of mortality and morbidity.
Nevertheless, more cancer patients are expected in the years to come, as life expectancy increases and other chronic diseases are better controlled.
But the horizon seems to get clearer in the Oncology area. Cancer heterogeneity is a challenge that may be partly solved through next generation sequencing of tumor genomes. New targets will fuel the cancer tailored treatments. Fresh tumor engraftment and expansion in animals will allow targeted therapies to be tested for each individual tumor. In addition, the development of more precise robotic surgical devices will allow less traumatic surgeries and nanotechnology will enable the development of new ways to deliver drugs more effectively to cancer cells.
In the last 100 years, from the mustard gas, used on the trenches of the I World War, the first chemotherapy agent was developed. For the next 100 years we can preview a new era on cancer treatment based on tumor targets and personalized treatment.
